May 17, 2024
Focusing on the potential effects for medical cannabis patients, Americans for Safe Access held a high-level presentation and discussion on the rescheduling of cannabis.
May 16, 2024
The US Attorney General has initiated the process to reclassify cannabis from a Schedule I to a less-restrictive Schedule III substance.
May 15, 2024
In this quick, onsite interview, Program Chair of the Compliance Track, Kim Stuck, shares the biggest buzz from the Cannabis Science Conference Spring 2024.
May 09, 2024
During Day 1’s General Session Kim Stuck, The Canna Consortium, moderated a panel featuring David Vaillencourt of S3 Collective, Ken Sobel Esq., and Susan Audino of S.A. Audino & Associates, LLC, where they shared their perspectives on cannabis’s recent federal rescheduling to Schedule III.
May 01, 2024
There have been a few changes when it comes to Organic Certification that you might not know about, so I’ll be dedicating this month’s blog to a certification opportunity for the hemp industry.
April 30, 2024
Multiple sources have reported that the US Drug Enforcement Administration will move to reclassify marijuana from Schedule I to Schedule III, effectively recognizing medical uses of cannabis and its reduced potential for abuse compared with other drugs.
April 20, 2024
In recognizing the 4/20 holiday, here is a selection of regulatory updates and commentary in the cannabis industry this year so far.
The cannabis business license application system has raised concerns with several stakeholders.
April 16, 2024
A collection of our most recent webinar coverage discussing medical research and testing methods.
April 10, 2024
Several efforts have been made to limit the prevalence of intoxicating hemp products.